Jaretzki 2000 MGFA Clinical Classification (Table 1). Caller-assigned class I, IIa, IIb, IIIa, IIIb, IVa, IVb, or V with the published description. Class V is intubation except routine postoperative management. A feeding tube without intubation is class IVb. Not QMG, not MG-ADL, not Osserman, and not an outcome measure (QMG is separate). magent does not examine the patient. Not a medical device.

McMillan 2007 modified Glasgow Prognostic Score (mGPS) from CRP in mg/L and albumin. Elevated CRP is >10 mg/L; hypoalbuminaemia is albumin <35 g/L. mGPS 0 when CRP ≤10 (albumin ignored, including isolated hypoalbuminaemia); mGPS 1 when CRP >10 and albumin ≥35; mGPS 2 when CRP >10 and albumin <35. Not original GPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.

Marburg Heart Score (Bösner 2010 Table 3): five 1-point determinants (age/sex, known vascular disease, patient assumes cardiac origin, pain worse with exercise, pain not reproducible by palpation), max 5. Returns the published discrimination cut-off: positive (3-5) or negative (<=2). Primary-care chest-pain rule only; not an ED ACS rule-out, diagnosis, or admission order. magent does not interview the patient.

Chopra 2017 Michigan Risk Score for PICC-associated thrombosis: another CVC at PICC placement 1, WBC >12 x10^9/L 1 (12.0 does not score), active cancer 2, PICC lumens single 0 / double 2 / triple 3 (triple includes quad), VTE history never 0 / remote 2 / within 30 days 3 (one field; do not add remote and recent). Max 10. Classes I=0 (observed 0.9%), II=1-2 (1.6%), III=3-4 (2.7%), IV=>4 (4.7% Table 4). Not a PICC order. magent does not count lumens.

Stewart 1999 MIDAS from five caller-assigned 3-month day counts: missed paid work/school, work/school ≥50% reduced, missed household work, household ≥50% reduced, missed family/social/leisure. Each 0-90; total 0-450. magent does not include questions A or B and does not assign or de-duplicate days. Grades I 0-5 little/minimal, II 6-10 mild, III 11-20 moderate, IV ≥21 severe. Not a migraine diagnosis, not a triptan/prophylaxis order, not GAD-7 or PHQ-9.

Mazzaferro 1996 Milan criteria for small HCC in cirrhosis: meets_milan is true iff there is no preoperative vascular invasion, no extrahepatic or lymph-node disease, and either one tumor 5 cm or less or two to three nodules each 3 cm or less. Four or more nodules fail. tumor_count and largest_cm are caller-assigned; magent does not interpret imaging. Not a medical device, not a transplant listing, and not UCSF criteria.

Adult maximum normal erythrocyte sedimentation rate (mm/h, 98th percentile approximation) from age and sex (Miller 1983). Men: age/2. Women: (age + 10)/2. Deterministic published arithmetic with citation. Returns the threshold only; not a diagnosis, not a measured ESR, and not Wener 2000 CRP. magent does not measure ESR.

Hoster 2008 simplified MIPI for advanced-stage mantle cell lymphoma: age (<50 0, 50–59 1, 60–69 2, ≥70 3), ECOG (0–1 0, 2–4 2), LDH/ULN (<0.67 0, 0.67–<1 1, 1–<1.5 2, ≥1.5 3), WBC ×10^9/L (<6.7 0, 6.7–<10 1, 10–<15 2, ≥15 3); max 11. Low 0–3, intermediate 4–5, high 6–11. Deterministic published score with citation; not a lymphoma diagnosis; not continuous MIPI; not MIPI-c. magent does not assay LDH or WBC.

Guglielmelli 2018 MIPSS70 for transplant-age PMF: Hb <10 g/dL (1), leukocytes >25×10^9/L (2), platelets <100×10^9/L (2), blasts ≥2% (1), fibrosis ≥2 (1), symptoms (1), no type 1/like CALR (1), HMR category (1), ≥2 HMR (2); max 12. Low 0–1, intermediate 2–4, high ≥5. Italian-cohort median (5-year) OS 27.7 y (95%), 7.1 y (70%), 2.3 y (29%). Not MIPSS70-plus or version 2.0. magent does not sequence or grade marrow.

Mirels 1989 impending pathologic fracture score. Site upper 1 / lower 2 / peritrochanteric 3. Size lt_one_third 1 / one_to_two_thirds 2 / gt_two_thirds 3. Nature blastic 1 / mixed 2 / lytic 3. Pain mild 1 / moderate 2 / functional 3 (not severe). Sum 4-12. Bands le_7 (<=7), 8, ge_9 (>=9). Not an operative order. Not SINS. magent does not read radiographs. Not a medical device.

CDC 2022 morphine milligram equivalents from a published opioid key and dose (mg/day, or mcg/hr for fentanyl_transdermal). Estimates only; do not use MME to convert one opioid to another. Not a taper protocol or OUD dosing tool.

DeCarolis 2007 MINDS (Minnesota Detoxification Scale) 0-46: pulse and diastolic BP lt_90/90_to_110/gt_110 → 0/1/2; tremor and sweat 0/2/4/6; hallucinations 0-3; agitation 0/3/6/9; orientation 0/2/4/6 (intubated 0); delusions and seizures 6 if true. magent publishes those DeCarolis 2007 weights, not a RASS modification, and does not examine the patient. Not a benzodiazepine order.

Mahler 1988 modified Medical Research Council (mMRC) dyspnea grade 0-4 as assigned by the caller. Returns the grade, score (same as grade), max 4, and published wording (breathless only with strenuous exercise through too breathless to leave the house or breathless when dressing). Not GOLD ABE groups, not a BODE index, and not Bestall MRC grades 1-5. magent does not examine the patient.

Meyer/Lyden 2001 modified NIH Stroke Scale (mNIHSS): eleven caller-assigned NINDS-style integers. Drops LOC, facial palsy, limb ataxia, and dysarthria; collapses sensory to 0 = normal or 1 = abnormal; keeps left/right motor arm and leg (each 0-4). Sum 0-31. magent does not examine the patient. No total-score severity bands in Meyer 2001; later website cutoffs are not applied. Not Brott 1989 NIHSS, not a tPA order, not a diagnosis, and not a medical device.

Frontera 2006 modified Fisher CT grades 0-4 for subarachnoid hemorrhage as assigned from CT by the caller. Returns the published grade and description (0 no SAH or IVH; 1 focal or diffuse thin SAH, no IVH; 2 thin SAH with IVH; 3 thick SAH, no IVH; 4 thick SAH with IVH). Not Fisher 1980 original groups 1-4. Not a diagnosis; magent does not read the CT or invent a millimetre cutoff or vasospasm percentage.

Goetz 2004 modified Hoehn and Yahr stage (Table 1). Caller-assigned tokens 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, or 5.0 with the published description. No stage 0. Not the original integer-only 1-5 scale, not UPDRS, not a diagnosis, and not an outcome measure. magent does not examine the patient. Not a medical device.

Modified Rankin handicap grade 0-5 (van Swieten 1988) as assigned by the caller. Returns the published wording (no symptoms at all through severe disability: bedridden, incontinent, constant nursing). This 1988 scale has six grades 0-5 and does not include a dead grade. Not a diagnosis or discharge/disability-benefit protocol; magent does not interview the patient.

Smith 2012 unweighted modified Sgarbossa for STEMI equivalent in LBBB. Positive if ANY of three caller-assigned flags is true: concordant ST elevation ≥1 mm in a lead with positive QRS, concordant ST depression ≥1 mm in V1–V3, or ≥1 mm discordant STE with ST/S ratio ≤ −0.25 (STE ≥25% of the preceding S-wave). Not the original Sgarbossa 1996 5/3/2 points score. Not a 5 mm discordant rule. magent does not measure the ECG. Not a diagnosis.

Satsangi 2006 Montreal IBD phenotype (Vienna revision). Crohn: A1-A3, L1-L4, B1-B3, optional +L4 (not when isolated L4) and p. UC: E1-E3 plus S0-S3 as assigned. Compact string, no spaces. Not an activity index (not CDAI/Mayo), not Paris, not IBDU. magent does not perform endoscopy. Not a diagnosis. Not a medical device.

Motzer 1999 MSKCC: KPS <80, LDH >1.5×ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, no prior nephrectomy; 1 point each, max 5. Favorable 0, intermediate 1–2, poor ≥3. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation; not IMDC; not Motzer 2002/2004. magent does not assign KPS or assay LDH, hemoglobin, or calcium.

Gwynn 2019 MRC-ICU: 39 printed ICU medication and device items (1, 2, or 3 points). Multiplier classes are weight × the caller-assigned count of qualifying medications. Non-multiplier items add the printed weight when present. Output is the integer sum plus components. Not a pharmacist-staffing order; magent does not read the MAR.

Lencioni 2010 mRECIST for typical intrahepatic HCC target lesions. First-match: PD if new_lesion or a 20% or greater viable-sum increase vs nadir; else CR if arterial enhancement disappeared in all targets; else PR if a 30% or greater viable-sum decrease vs baseline; else SD. Caller-assigned flags; magent does not read imaging. Not a medical device, not a diagnosis, not RECIST 1.1, not EASL necrosis-only, not the 2019 Llovet +5 mm PD refinement, and not nontarget-only overall response.

mSOAR (Abdul-Rahim 2016 Stroke): SOAR plus NIHSS for early mortality after acute stroke. Age ≤65 0, 66-85 1, >85 2; infarct 0, hemorrhage 1; OCSP LACS/PACS 0, POCS 1, TACS 2; prestroke mRS 0-2 0, 3-4 1, 5 2; NIHSS 0-4 0, 5-10 1, ≥11 2. Max 9. Table 2 derivation percents for scores 0-1 through 7. Not a care-withdrawal decision. magent does not examine the patient or score NIHSS items.

Modified SOFA (mSOFA) from Grissom 2010 Table 2: SpO2/FiO2 respiration, caller-assigned scleral icterus or jaundice (0 or 3), MAP and adrenergic agents, caller-assigned GCS, and creatinine; five organs, coagulation not scored, max 19. Deterministic published score with citation; not Vincent 1996 SOFA, not qSOFA, and not a Sepsis-3 diagnosis.

Lipton 2015 mTOQ-4 from four caller-assigned frequency items: pain-free within 2 hours, one dose keeps headache away ≥24 hours, comfortable enough to plan daily activities, in control enough to return to normal function. Each never=0, rarely=0, less_than_half=1, half_or_greater=2. Sum 0-8. Bands very_poor 0, poor 1-5, moderate 6-7, maximum 8. magent does not interview the patient. Not a diagnosis, not an abortive-drug order, not the 19-item or 6-item mTOQ.

Guo 2019 MuLBSTA viral pneumonia mortality score. Caller-assigned multilobular infiltrates (5), lymphocyte count ≤0.8 ×10^9/L (4), bacterial coinfection (4), exclusive smoking (never 0, former 2, current 3), hypertension (2), and age ≥60 (2). Max 20. Low 0-11, high ≥12. magent does not read imaging or assign smoking history. Not a viral-species diagnosis or treatment order.

Mumtaz 2019 integer score for 30-day all-cause readmission after decompensated-cirrhosis index admission. Age, payer, caller-assigned Elixhauser >=3, nonalcoholic etiology, ascites, encephalopathy, variceal bleeding (-7), HCC, paracentesis, hemodialysis, and disposition. Range -11 to 49. Returns estimated_readmission_percent and readmission_band (low <20%, medium 20-30%, high >30%). Not a discharge order. magent does not compute Elixhauser.

Murray 1988 lung injury score (LIS): mean of four 0–4 components (caller-assigned CXR quadrants; PaO2/FiO2 ≥300→0, 225–299→1, 175–224→2, 100–174→3, <100→4; PEEP cm H2O ≤5→0, 6–8→1, 9–11→2, 12–14→3, ≥15→4; compliance mL/cm H2O ≥80→0, 60–79→1, 40–59→2, 20–39→3, ≤19→4). LIS 0 none, 0<LIS≤2.5 mild_moderate, >2.5 severe. Not a medical device, not a Berlin ARDS diagnosis, not a ventilator order. magent does not interpret imaging.

Stratton 2004 Malnutrition Universal Screening Tool (MUST) for adults. Three additive scores, max 6: BMI (>20 → 0, 18.5–20 → 1 including 20.0, <18.5 → 2); unplanned weight loss % last 3–6 months (<5 → 0, 5–10 → 1 including 10%, >10 → 2); acute disease no nutritional intake >5 days → 2. Risk 0 low, 1 medium, ≥2 high. Caller supplies BMI and weight-loss percent. Not a malnutrition diagnosis, diet order, or MUAC. magent does not weigh the patient.

Greipp 2005 International Staging System for multiple myeloma. Stage I: serum beta-2 microglobulin <3.5 mg/L and albumin >=3.5 g/dL. Stage III: beta-2 microglobulin >=5.5 mg/L. Stage II: neither I nor III. Returns iss_stage 1/2/3. Not a myeloma diagnosis or treatment choice; not R-ISS (no LDH, no cytogenetics); not trauma ISS. magent does not assay beta-2 microglobulin or albumin.

Passamonti 2017 MYSEC-PM for post-PV and post-ET myelofibrosis. Score = 0.15*age + hemoglobin <11 g/dL (2) + circulating blasts ≥3% (2) + CALR-unmutated (2) + platelets <150×10^9/L (1) + constitutional symptoms (1). Low <11, intermediate_1 ≥11 and <14, intermediate_2 ≥14 and <16, high ≥16. Not DIPSS (PMF), not GIPSS, not a transplant listing. magent does not sequence CALR.

Popoveniuc 2014 myxedema coma points from caller-assigned bands: thermoregulatory 0/10/20; CNS 0/10/15/20/30; GI 0/5/15/20; precipitant 10; bradycardia 0/10/20/30 plus other EKG 10, effusion 10, pulmonary edema 15, cardiomegaly 15, hypotension 20; five metabolic flags 10 each. Max 230. ≥60 potentially diagnostic; 45–59 at risk. Not a diagnosis or thyroid-hormone order. magent does not measure temperature, GCS, or labs.

Nadler 1962 predicted blood volume in liters from height, weight, and sex (separate male and female equations). Deterministic published arithmetic with citation. For adults as published; this tool does not take age. Not a transfusion order, Lemmens–Bernstein–Brodsky estimate, or 70 mL/kg rule of thumb.

Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG >880 mg/dL or >10 mmol/L, TG/TC >8 (mg/dL) or >3.5 (mmol/L), and apo B <1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.

Angulo 2007 NAFLD fibrosis score from age, BMI, IFG/diabetes, AST, ALT, platelets, and albumin. Deterministic published equation with citation. Not a biopsy or diagnosis. Not FIB-4, APRI, or BARD.

Kleiner 2005 NAFLD activity score (NAS): caller-assigned steatosis 0-3 (<5% / 5–33% / >33–66% / >66%), lobular_inflammation 0-3 (none / <2 foci per 200× / 2–4 / >4), ballooning 0-2 (none / few / many or prominent). magent sums only (max 8). Fibrosis is not in NAS. Kleiner 2005 reported NAS ≥5 correlated with NASH in that study; that is not a diagnostic algorithm. magent does not read histology and does not return NASH bands.

Continuous intravenous naloxone infusion as two-thirds of the caller-assigned reversal bolus each hour (Goldfrank 1986). infusion_mg_h = (2/3) * reversal_bolus_mg maintains plasma naloxone at or above the 30-minute post-bolus level. magent does not choose the bolus or start naloxone. Not a prescription or medical device.

Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.

NCI CTC v2.0 Mucositis due to radiation (Trotti 2000). none → 0; erythema → 1; patchy_pseudomembrane (≤1.5 cm, noncontiguous) → 2; confluent_pseudomembrane (contiguous >1.5 cm) → 3; necrosis_or_deep_ulcer (may include bleeding not induced by minor trauma) → 4. magent does not examine the mucosa. Not CTC stomatitis/pharyngitis, CTCAE v3/v4/v5, or WHO mucositis. Not a diagnosis or medical device.

NCI CTC v2.0 stomatitis/pharyngitis (Trotti 2000). none → 0; painless_or_mild_soreness → 1; painful_can_eat → 2; painful_cannot_eat → 3; parenteral_or_prophylactic_intubation → 4. magent does not examine the mucosa. Not radiation mucositis (nci-ctc-mucositis), CTCAE catalog, or WHO. Not a diagnosis or medical device.

Vernon 1991 Neck Disability Index: ten caller-assigned integers 0-5 (pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping, recreation). Sum 0-50. Vernon 1991 raw-score bands 0-4 none, 5-14 mild, 15-24 moderate, 25-34 severe, >34 complete. Does not apply later 0-8%/10-28% website percentage bands or score Oswestry. magent does not interview. Not a diagnosis and not a medical device.

Weiss 2004 National ED Overcrowding Study (NEDOCS) reduced five-variable model: ED patients indexed to ED beds, boarding indexed to hospital beds, respirators, longest admitted-patient hours since registration, and last-called registration-to-bed hours. Returns the linear score (1 decimal) and the published ≥100 overcrowding cutoff. Caller supplies counts and hours; magent does not count beds or wait times. Not a medical device and not a diversion or ambulance-bypass order.

Puopolo 2011 neonatal early-onset sepsis prior at birth (≥34 weeks) from maternal temperature, gestational age, ROM, GBS, and antibiotic timing, then Escobar 2014 posterior after a caller-assigned well, equivocal, or ill exam. Incidence intercepts 0.3-0.6 per 1000 replace the printed 47.8398 constant. Not a sepsis diagnosis or antibiotic order. magent does not examine the infant.

Partial-exchange volume from Kumar 2004: volume_ml = (actual_hct_percent - 55) / actual_hct_percent * blood_volume_ml. Desired hematocrit is the trial's 55 percent only. Caller assigns blood volume; magent does not choose millilitres per kilogram or saline versus plasma. Not a transfusion order or indication (the trial found no long-term benefit in asymptomatic LBW). Deterministic published arithmetic with citation.

New Orleans Head CT Rule (Haydel 2000). CT is indicated if any of seven findings: headache, vomiting, age over 60, drug or alcohol intoxication, short-term memory deficit (anterograde amnesia), physical evidence of trauma above the clavicles, or seizure. Published for GCS 15 minor head injury in adults; magent does not take GCS or examine the patient. Not a diagnosis, not the Canadian CT Head Rule, not PECARN, and not pediatric.

NEWS from RCP 2012 Chart 1: respiratory rate, SpO2, supplemental oxygen, temperature (°C), systolic BP, heart rate, and caller-assigned AVPU (alert 0; voice, pain, or unresponsive 3 each) summed to a 0–20 total. Returns Chart 2 clinical_risk (low/medium/high) and red_score when any parameter scores 3. Deterministic published arithmetic with citation; not NEWS2; not an ICU-admission order.

NEWS2 from RCP 2017 Chart 1: respiratory rate, SpO2 on caller-assigned Scale 1 or Scale 2, supplemental oxygen, temperature (C), systolic BP, heart rate, and caller-assigned ACVPU (alert 0; confusion, voice, pain, or unresponsive 3 each) summed to 0-20. Returns Chart 2 clinical_risk (low / low-medium / medium / high) and red_score. Not NEWS 2012; not an ICU-admission order.

Newsom 2014 modified Rothrock rule for chest radiography in nontraumatic emergency chest pain. CXR indicated if any of: age ≥65 years, history of congestive heart failure, history of alcohol abuse, decreased breath sounds, fever, or tachypnea. Does not include hypoxia, rales, hemoptysis, tuberculosis, or thromboembolic disease (removed in 2014). Not the 2018 prospective refinement. Caller assigns age and five flags. magent does not examine the patient or read a radiograph. Not a diagnosis.

NEXUS C-spine rule (Hoffman 2000). The patient is NEXUS low-risk, and imaging is not indicated by this rule, only when all five hold: no posterior midline cervical-spine tenderness, no focal neurologic deficit, normal alertness, no intoxication, and no painful distracting injury. Any failed criterion means x-ray is indicated. Not a diagnosis, not the Canadian C-spine rule, and not NEXUS chest. Blunt-trauma adults as published. magent does not examine the patient.

NEXUS Chest (Rodriguez 2011). Chest radiography is not indicated by this instrument only when all seven caller-assigned findings are absent: chest pain, distracting injury, chest-wall tenderness, intoxication, age >60, rapid deceleration, and altered mental status. Any one present means chest x-ray is indicated. Not a diagnosis, not Hoffman 2000 NEXUS C-spine, and not a NEXUS Chest CT instrument. Derivation enrolled blunt trauma age >14. magent does not examine the patient.